LTR Pharma Limited (AU:LTP) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
LTR Pharma Limited has partnered with Men’s Health Downunder to provide its innovative erectile dysfunction treatment, SPONTAN®, through an established pharmacy network in Australia. This collaboration leverages Men’s Health Downunder’s extensive referral network and is a strategic step in commercializing SPONTAN®, aiming for broader market access by early 2025. The partnership underscores LTR Pharma’s commitment to enhancing men’s health through trusted healthcare providers.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.